Your email has been successfully added to our mailing list.

×
0.00650759219088942 -0.00216919739696308 -0.00108459869848154 0.00325379609544462 0.00291757049891534 -0.0108459869848156 -0.00433839479392635 0.0151843817787419
Stock impact report

Choroidal Neovascularization Clinical Trials by G7 Countries: Proportion of Choroidal Neovascularization to Ophthalmology Clinical Trials - ResearchAndMarkets.com

NeuBase Therapeutics, Inc. (NBSE) 
Last neubase therapeutics, inc. earnings: 3/26 04:05 pm Check Earnings Report
Company Research Source: Business Wire
DUBLIN--(BUSINESS WIRE)--The "Choroidal Neovascularization Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report, "Choroidal Neovascularization Global Clinical Trials Review, H1, 2020" provides top line data relating to the clinical trials on Choroidal Neovascularization. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).Scope of the report:The report provides a snapshot of the global clinical trials landscapeThe report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point statusThe report reviews top companie Show less Read more
Impact Snapshot
Event Time:
NBSE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NBSE alerts
Opt-in for
NBSE alerts

from News Quantified
Opt-in for
NBSE alerts

from News Quantified